Surinder Kumar Batra
Overview
Explore the profile of Surinder Kumar Batra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maurya S, Jaramillo-Gomez J, Rehman A, Gautam S, Fatima M, Khan M, et al.
Clin Cancer Res
. 2025 Jan;
31(5):921-935.
PMID: 39760691
Purpose: Breast cancer brain metastasis remains a significant clinical problem. Mucins have been implicated in metastasis; however, whether they are also involved in breast cancer brain metastasis remains unknown. We...
2.
Abdullah K, Kaushal J, Takkar S, Sharma G, Alsafwani Z, Pothuraju R, et al.
Heliyon
. 2024 Mar;
10(5):e27496.
PMID: 38486750
Copper, a vital trace element, orchestrates diverse cellular processes ranging from energy production to antioxidant defense and angiogenesis. Copper metabolism and cuproptosis are closely linked in the context of human...
3.
Ahmad A, Khan P, Rehman A, Batra S, Nasser M
Mol Cancer
. 2023 Jul;
22(1):111.
PMID: 37454123
The diagnosis of brain metastasis (BrM) has historically been a dooming diagnosis that is nothing less than a death sentence, with few treatment options for palliation or prolonging life. Among...
4.
Khan P, Siddiqui J, Kshirsagar P, Chirravuri Venkata R, Maurya S, Mirzapoiazova T, et al.
Mol Cancer
. 2023 Jan;
22(1):1.
PMID: 36597126
Background: Small cell lung cancer (SCLC) is an aggressive lung cancer subtype that is associated with high recurrence and poor prognosis. Due to lack of potential drug targets, SCLC patients...
5.
Sharma G, Sultana A, Abdullah K, Pothuraju R, Nasser M, Batra S, et al.
Semin Cell Dev Biol
. 2022 Nov;
154(Pt C):275-285.
PMID: 36379849
Bone remodeling is a continuous and dynamic process of bone formation and resorption to maintain its integrity and homeostasis. Bone marrow is a source of various cell lineages, including osteoblasts...
6.
Khan P, Fatima M, Khan M, Batra S, Nasser M
Semin Cancer Biol
. 2022 Nov;
87:117-126.
PMID: 36371025
Small cell lung cancer (SCLC) is a recalcitrant, relatively immune-cold, and deadly subtype of lung cancer. SCLC has been viewed as a single or homogenous disease that includes deletion or...
7.
Mughees M, Kaushal J, Sharma G, Wajid S, Batra S, Siddiqui J
Semin Cancer Biol
. 2022 Feb;
86(Pt 3):497-512.
PMID: 35181473
Chemokines are recognized as the major contributor to various tumorigenesis, tumor heterogeneity, and failures of current cancer therapies. The tumor microenvironment (TME) is enriched with chemokines and cytokines and plays...
8.
Sharma G, Pothuraju R, Kanchan R, Batra S, Siddiqui J
Semin Cancer Biol
. 2022 Feb;
86(Pt 3):457-472.
PMID: 35124194
Chemokines are well equipped with chemo-attractive signals that can regulate cancer cell trafficking to specific organ sites. Currently, updated concepts have revealed the diverse role of chemokines in the biology...
9.
Siddiqui J, Seshacharyulu P, Muniyan S, Pothuraju R, Khan P, Vengoji R, et al.
Bone Res
. 2022 Jan;
10(1):6.
PMID: 35058441
Bone metastases occur in patients with advanced-stage prostate cancer (PCa). The cell-cell interaction between PCa and the bone microenvironment forms a vicious cycle that modulates the bone microenvironment, increases bone...
10.
Nam A, Mohanty A, Bhattacharya S, Kotnala S, Achuthan S, Hari K, et al.
Biomolecules
. 2022 Jan;
12(1).
PMID: 35053156
Drug resistance, a major challenge in cancer therapy, is typically attributed to mutations and genetic heterogeneity. Emerging evidence suggests that dynamic cellular interactions and group behavior also contribute to drug...